|
Glenmark Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 48.26 | 37.11 | -53.22 | 10.53 | 33.37 |
| Diluted EPS (Rs.) | 48.24 | 37.11 | -53.22 | 10.53 | 33.37 |
| Cash EPS (Rs.) | 68.58 | 54.33 | -30.18 | 35.04 | 52.46 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 372.51 | 313.60 | 278.09 | 348.70 | 334.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 372.51 | 313.60 | 278.09 | 348.70 | 334.48 |
| Revenue From Operations / Share (Rs.) | 601.79 | 472.08 | 418.62 | 460.36 | 436.08 |
| PBDIT / Share (Rs.) | 178.35 | 87.36 | 72.13 | 91.97 | 88.14 |
| PBIT / Share (Rs.) | 158.03 | 70.13 | 51.50 | 70.31 | 70.89 |
| PBT / Share (Rs.) | 70.33 | 49.58 | 1.29 | 30.78 | 51.08 |
| Net Profit / Share (Rs.) | 48.26 | 37.11 | -50.80 | 13.37 | 35.21 |
| NP After MI And SOA / Share (Rs.) | 48.26 | 37.11 | -53.21 | 10.53 | 33.37 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 29.63 | 18.50 | 17.22 | 19.97 | 20.21 |
| PBIT Margin (%) | 26.25 | 14.85 | 12.30 | 15.27 | 16.25 |
| PBT Margin (%) | 11.68 | 10.50 | 0.30 | 6.68 | 11.71 |
| Net Profit Margin (%) | 8.01 | 7.86 | -12.13 | 2.90 | 8.07 |
| NP After MI And SOA Margin (%) | 8.01 | 7.86 | -12.71 | 2.28 | 7.65 |
| Return on Networth / Equity (%) | 12.95 | 11.83 | -19.13 | 3.13 | 10.36 |
| Return on Capital Employeed (%) | 32.95 | 19.62 | 17.01 | 13.84 | 16.13 |
| Return On Assets (%) | 6.84 | 6.52 | -10.45 | 1.53 | 5.51 |
| Long Term Debt / Equity (X) | 0.00 | 0.05 | 0.00 | 0.40 | 0.28 |
| Total Debt / Equity (X) | 0.00 | 0.24 | 0.12 | 0.45 | 0.40 |
| Asset Turnover Ratio (%) | 0.94 | 0.87 | 0.70 | 0.71 | 0.42 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.77 | 1.56 | 1.28 | 1.96 | 1.77 |
| Quick Ratio (X) | 1.23 | 1.05 | 0.84 | 1.37 | 1.23 |
| Inventory Turnover Ratio (X) | 5.26 | 4.81 | 1.15 | 1.31 | 1.85 |
| Dividend Payout Ratio (NP) (%) | 10.36 | 6.73 | -4.69 | 23.73 | 7.49 |
| Dividend Payout Ratio (CP) (%) | 7.29 | 4.60 | -7.66 | 7.76 | 4.93 |
| Earning Retention Ratio (%) | 89.64 | 93.27 | 104.69 | 76.27 | 92.51 |
| Cash Earning Retention Ratio (%) | 92.71 | 95.40 | 107.66 | 92.24 | 95.07 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 24.11 | 11.90 | 3.94 | 7.42 | 8.34 |
| Interest Coverage Ratio (Post Tax) (%) | 18.38 | 7.86 | -0.80 | 4.27 | 5.21 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 59025.15 | 43947.27 | 26350.45 | 16364.27 | 15087.86 |
| EV / Net Operating Revenue (X) | 3.48 | 3.30 | 2.23 | 1.26 | 1.23 |
| EV / EBITDA (X) | 11.73 | 17.83 | 12.95 | 6.31 | 6.07 |
| MarketCap / Net Operating Revenue (X) | 3.54 | 3.26 | 2.29 | 1.01 | 1.01 |
| Retention Ratios (%) | 89.63 | 93.26 | 104.69 | 76.26 | 92.50 |
| Price / BV (X) | 5.73 | 4.91 | 3.44 | 1.38 | 1.37 |
| Price / Net Operating Revenue (X) | 3.54 | 3.26 | 2.29 | 1.01 | 1.01 |
| EarningsYield | 0.02 | 0.02 | -0.05 | 0.02 | 0.07 |
